Lexington Biosciences Inc. (LXGTF)

[LittleBlondie]

LXGTF Engages Clinical Research Organization recently!

“WITH TODAY’S (11/30/17) ANNOUNCEMENT (LXGTF)’S PLANS ARE NOW ADVANCING TO INITIATE COMMENCEMENT OF A PILOT CLINICAL RESEARCH STUDY DESIGNED TO BEGIN GATHERING THE FOUNDATIONAL DATASET AIMED AT SUPPORTING FDA CLEARANCE.”

VANCOUVER, BC–(Marketwired – Nov 30, 2017) – Lexington Biosciences, Inc. ( CSE : LNB ) ( OTCQB : LXGTF ) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to announce the engagement of San Francisco Bay Area-based Diablo Clinical Research to conduct its upcoming HeartSentry pilot clinical studies.